MRI assessment of relapsed glioblastoma during treatment with bevacizumab: Volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression—A pilot study

Josef Pichler, Corinna Pachinger, Manuela Pelz, Raimund Kleiser

Open source

DOI
10.1016/j.ejrad.2012.12.018
Published
2013-05
Container
European Journal of Radiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejrad.2012.12.018,
  title = {MRI assessment of relapsed glioblastoma during treatment with bevacizumab: Volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression—A pilot study},
  author = {Josef Pichler and Corinna Pachinger and Manuela Pelz and Raimund Kleiser},
  year = {2013},
  journal = {European Journal of Radiology},
  doi = {10.1016/j.ejrad.2012.12.018},
  url = {https://doi.org/10.1016/j.ejrad.2012.12.018}
}

RIS

TY  - JOUR
TI  - MRI assessment of relapsed glioblastoma during treatment with bevacizumab: Volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression—A pilot study
AU  - Josef Pichler
AU  - Corinna Pachinger
AU  - Manuela Pelz
AU  - Raimund Kleiser
PY  - 2013
JO  - European Journal of Radiology
DO  - 10.1016/j.ejrad.2012.12.018
UR  - https://doi.org/10.1016/j.ejrad.2012.12.018
ER  - 

APA

Pichler, J., Pachinger, C., Pelz, M., & Kleiser, R. (2013). MRI assessment of relapsed glioblastoma during treatment with bevacizumab: Volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression—A pilot study. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2012.12.018

Source records